ERYTECH PHARMA (ERYP.PA) Stock Price, Quote, News and Overview
EPA:ERYP - Euronext Paris - Matif - FR0011471135 - Common Stock - Currency: EUR
ERYP.PA Quote, Performance and Key Statistics
EPA:ERYP (6/28/2023, 7:00:00 PM)
0.801
+0 (+0.25%)
The current stock price of ERYP.PA is 0.801 EUR. In the past month the price decreased by -8.56%. In the past year, price decreased by -28.23%.
ERYP.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 18.25 | 298.60B | ||
| AMG.DE | AMGEN INC | 13.18 | 132.40B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 13.27 | 115.15B | ||
| GIS.DE | GILEAD SCIENCES INC | 13.2 | 114.56B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | N/A | 100.62B | ||
| 1REGN.MI | REGENERON PHARMACEUTICALS | 11.72 | 52.64B | ||
| ARGX.BR | ARGENX SE | 102.29 | 30.11B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 20.88B | ||
| IDP.DE | BIOGEN INC | 7.79 | 16.26B | ||
| 1MRNA.MI | MODERNA INC | N/A | 8.85B | ||
| 0QF.DE | MODERNA INC | N/A | 8.76B | ||
| BIO.DE | BIOTEST AG | 65.54 | 1.69B |
Related stock screener links
About ERYP.PA
Company Profile
ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The company is headquartered in Lyon, Auvergne-Rhone-Alpes and currently employs 49 full-time employees. The company went IPO on 2013-05-07. The firm offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The firm's technology is based on the use of human red blood cells (RBCs) to improve the pharmacokinetic (PK) and pharmacodynamic (PD) properties of therapeutic enzymes, for instance asparaginase. The enzyme can destroy asparagine and deprive cancer cells of an important nutrient for these cells, resulting in their death.
Company Info
ERYTECH PHARMA
60 avenue Rockefeller, Batiment Adenine
Lyon AUVERGNE-RHONE-ALPES FR
Employees: 49
Phone: 33478744438.0
ERYTECH PHARMA / ERYP.PA FAQ
What is the stock price of ERYTECH PHARMA today?
The current stock price of ERYP.PA is 0.801 EUR. The price increased by 0.25% in the last trading session.
What is the ticker symbol for ERYTECH PHARMA stock?
The exchange symbol of ERYTECH PHARMA is ERYP and it is listed on the Euronext Paris - Matif exchange.
On which exchange is ERYP.PA stock listed?
ERYP.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for ERYTECH PHARMA stock?
9 analysts have analysed ERYP.PA and the average price target is 3.67 EUR. This implies a price increase of 358.43% is expected in the next year compared to the current price of 0.801. Check the ERYTECH PHARMA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ERYTECH PHARMA worth?
ERYTECH PHARMA (ERYP.PA) has a market capitalization of 24.84M EUR. This makes ERYP.PA a Nano Cap stock.
How many employees does ERYTECH PHARMA have?
ERYTECH PHARMA (ERYP.PA) currently has 49 employees.
What are the support and resistance levels for ERYTECH PHARMA (ERYP.PA) stock?
ERYTECH PHARMA (ERYP.PA) has a support level at 0.78 and a resistance level at 0.81. Check the full technical report for a detailed analysis of ERYP.PA support and resistance levels.
Is ERYTECH PHARMA (ERYP.PA) expected to grow?
The Revenue of ERYTECH PHARMA (ERYP.PA) is expected to grow by 16.44% in the next year. Check the estimates tab for more information on the ERYP.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ERYTECH PHARMA (ERYP.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ERYP.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ERYP.PA, evaluating the profitability, health, valuation and growth aspects
- ERYTECH PHARMA (ERYP.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ERYTECH PHARMA (ERYP.PA) Sales and EPS estimates to see what analysts future expectations are.
- ERYTECH PHARMA (ERYP.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ERYTECH PHARMA (ERYP.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- ERYTECH PHARMA (ERYP.PA) Stock Chart to make your own analysis
- ERYTECH PHARMA (ERYP.PA) Latest news and press-releases to stay up to date.
Does ERYTECH PHARMA (ERYP.PA) stock pay dividends?
ERYP.PA does not pay a dividend.
What is the Price/Earnings (PE) ratio of ERYTECH PHARMA (ERYP.PA)?
ERYTECH PHARMA (ERYP.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.56).
ERYP.PA Technical Analysis
ERYP.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ERYP.PA. The financial health of ERYP.PA is average, but there are quite some concerns on its profitability.
ERYP.PA Financial Highlights
Over the last trailing twelve months ERYP.PA reported a non-GAAP Earnings per Share(EPS) of -0.56. The EPS increased by 99.68% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.44 |
ERYP.PA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 42% to ERYP.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 22.35% and a revenue growth 16.44% for ERYP.PA